Clinical Trial Update: Investigation of β-hydroxybutyrate Supplementation as Chemoprevention in Familial Adenomatous Polyposis [NA]

View source ↗

Summary

This clinical trial update reports ongoing recruitment for a study evaluating beta-hydroxybutyrate supplementation as chemoprevention in Familial Adenomatous Po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Familial Adenomatous Polyposis

Drugs mentioned

• beta-hydroxybutyrate (beta-hydroxybutyrate)

Snippet

Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: FAP, Familial Adenomatous Polyposis | NA | Status: RECRUITING